Metagenomic Sequencing Market by Workflow (Sample Preparation, Data Analysis), Product & Services (Reagents, Consumables, Instruments), Technology (Shotgun, 16s Rrna, Whole-Genome), Application (Diagnostic, Soil Microbiome) - Global Forecast to 2024

“The metagenomic sequencing market is projected to grow at a CAGR of 17.0%.”
The metagenomic sequencing market is projected to reach USD 2.3 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 17.0%. The growth of this market is driven by factors such as the significant applications of metagenomics in various fields, the various initiatives and funding from government & private bodies for large-scale sequencing projects, and the declining cost of sequencing.
“The reagents & consumables segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”

On the basis of product & service, the metagenomic sequencing market is segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. Of all these segments, reagents & consumables are expected to grow at the highest CAGR during the forecast period. Factors such as the development and commercialization of high-quality reagents and kits and the continuous requirement of sequencing reagents by end users are expected to drive the growth of the reagents & consumables market in the coming years.
“The sample processing & library preparation segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”

The market, based on workflow, has been segmented into sample processing & library preparation, sequencing, and data processing & analysis. The sample processing & library preparation segment projected to register the highest growth rate during the forecast period. This growth can be attributed to the growing number of metagenome sequencing research projects being conducted, the availability of technically advanced and robust sample processing and library preparation assay kits, and the demand for efficient library preparation products.
“The shotgun metagenomic sequencing technology segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”
On the basis of technology, the metagenomic sequencing market is segmented into shotgun metagenomic sequencing, 16S rRNA sequencing, metatranscriptomics, and whole-genome sequencing & de-novo assembly. The shotgun metagenomic sequencing technology is expected to witness the highest growth rate in the metagenomic sequencing market during the forecast period. This can be attributed to the advantages offered by shotgun sequencing over other techniques, growing adoption of shotgun metagenomic sequencing among researchers and healthcare professionals, and the increasing number of metagenomic sequencing-based research activities.
The drug discovery segment is expected to witness the highest growth in the metagenomic sequencing market during the forecast period.”
Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological and environmental applications, veterinary applications, and other applications. The drug discovery segment is poised to grow at the highest rate during the forecast period. Growth in this market segment is mainly due to the increasing research activities for novel drug discovery, growing collaborations between market players, academic institutions, and pharmaceutical companies for drug development, and growing use of metagenomic NGS in clinical trials.

“The Asia Pacific is expected to grow at the highest CAGR during the forecast period.”
The metagenomic sequencing market is segmented into four major regions, namely, North America, Europe, the Asia Pacific (APAC), and the Rest of the World (Latin America, the Middle East, and Africa). The Asia Pacific regional segment is expected to grow at the highest CAGR during the forecast period. Growth in this market segment is mainly due to a significant focus on R&D activities as a means of broadening the scope of metagenomics applications, increasing adoption of metagenomics for diagnostics (due to the decreasing cost of metagenomics products and services), and technological developments in metagenomics genomic data analysis as well as interpretation.

Breakdown of supply-side primary interviews:
‧ By Company Type: Tier 1 (25%), Tier 2 (30%), and Tier 3 (45%)
‧ By Designation: C-level (26%), Director-level (30%), and Others (44%)
‧ By Region: North America (34%), Europe (26%), APAC (23%), and RoW (17%)

The major players operating in the global metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc (US), QIAGEN N.V. (Netherlands), PerkinElmer (US), Oxford Nanopore Technologies Ltd (UK), BGI Group (China), Macrogen Inc. (South Korea), GENEWIZ (US), Eurofins Scientific (Luxembourg), Novogene Corporation (China), Zymo Research Corporation (US), NuGEN Technologies, Inc (US), IntegraGen SA (France), Microsynth AG (Switzerland), and DNAStar, Inc (US).
Research Coverage
This report studies the metagenomic sequencing market by product & service, workflow, technology, application, and region. It also covers factors affecting market growth, analyzes various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends and forecasts the size of market segments with respect to key regions—North America, Europe, the Asia Pacific, and the Rest of the World.

Reasons to Buy the Report:
From an insights perspective, this research report focuses on various levels of analysis—market ranking the analysis of the top players and their company profiles, which together comprise and discuss basic views on the competitive landscape; emerging segments of the metagenomic sequencing market and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY USED FOR THE STUDY 17
1.5 MARKET STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY DATA 20
2.1.2.1 Breakdown of primaries 21
2.1.2.2 Key data from primary sources 21
2.2 MARKET SIZE ESTIMATION 22
2.2.1 PRODUCT-BASED MARKET ESTIMATION 22
2.2.2 APPLICATION-BASED MARKET SIZE ESTIMATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 ASSUMPTIONS FOR THE STUDY 26
3 EXECUTIVE SUMMARY 27
4 PREMIUM INSIGHTS 31
4.1 METAGENOMIC SEQUENCING: MARKET OVERVIEW 31
4.2 METAGENOMIC SEQUENCING MARKET SHARE, BY PRODUCT & SERVICE
(2019 VS. 2024) 32
4.3 METAGENOMIC SEQUENCING MARKET SHARE, BY WORKFLOW (2019 VS. 2024) 32
4.4 METAGENOMIC SEQUENCING MARKET SHARE, BY TECHNOLOGY (2019 VS. 2024) 33
4.5 METAGENOMIC SEQUENCING MARKET, BY APPLICATION, (2019 VS. 2024) 34
4.6 METAGENOMIC SEQUENCING MARKET, BY REGION (2019–2024) 34
?
5 MARKET OVERVIEW 35
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Significant applications of metagenomics in various fields 36
5.2.1.2 Initiatives and funding from government & private bodies for large-scale sequencing projects 36
5.2.1.3 Declining cost of sequencing 37
5.2.2 RESTRAINTS 37
5.2.2.1 End-user budget constraints in developing countries 37
5.2.3 OPPORTUNITIES 37
5.2.3.1 Availability of cloud computing for data management 37
5.2.4 CHALLENGES 38
5.2.4.1 Storage of sequencing data 38
5.2.4.2 Dearth of skilled professionals 38
6 METAGENOMIC SEQUENCING MARKET, BY PRODUCT & SERVICE 39
6.1 INTRODUCTION 40
6.2 REAGENTS & CONSUMABLES 40
6.2.1 RISING ADOPTION OF METAGENOMIC SEQUENCING IS DRIVING THE USE OF REAGENTS AND CONSUMABLES 40
6.3 INSTRUMENTS 41
6.3.1 LAUNCH OF ADVANCED NGS PLATFORMS WILL SUPPORT THE GROWTH OF THIS SEGMENT 41
6.4 SERVICES 42
6.4.1 TIME AND COST-EFFECTIVENESS OF OUTSOURCING NGS PROJECTS HAS DRIVEN DEMAND FOR SERVICES 42
6.5 ANALYSIS AND DATA INTERPRETATION SOLUTIONS 43
6.5.1 LIMITED TECHNICAL KNOWLEDGE OF ADVANCED ANALYSIS SOLUTIONS AMONG END USERS TO HAMPER MARKET GROWTH 43
7 METAGENOMIC SEQUENCING MARKET, BY WORKFLOW 45
7.1 INTRODUCTION 46
7.2 SAMPLE PROCESSING & LIBRARY PREPARATION 46
7.2.1 SAMPLE PROCESSING & LIBRARY PREPARATION HOLDS THE LARGEST SHARE OF THE MARKET, BY WORKFLOW 46
7.3 SEQUENCING 47
7.3.1 SANGER SEQUENCING HAS BEEN SUPPLANTED BY NGS DUE TO ITS ADVANTAGES AND RAPIDITY 47
7.4 DATA PROCESSING & ANALYSIS 48
7.4.1 NEED FOR SKILLED PERSONNEL TO OPERATE DATA PROCESSING AND ANALYTICS TOOLS HAS SLOWED MARKET GROWTH 48
?
8 METAGENOMIC SEQUENCING MARKET, BY TECHNOLOGY 49
8.1 INTRODUCTION 50
8.2 16S RRNA SEQUENCING 50
8.2.1 16S RRNA SEQUENCING IS A COST-EFFECTIVE TECHNIQUE FOR THE IDENTIFICATION OF BACTERIAL STRAINS 50
8.3 SHOTGUN METAGENOMIC SEQUENCING 51
8.3.1 SHOTGUN METAGENOMIC SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 51
8.4 WHOLE-GENOME SEQUENCING AND DE NOVO ASSEMBLY 53
8.4.1 WGS CAN SEQUENCE THE COMPLETE METAGENOME OF ENVIRONMENTAL SAMPLES & HELPS GENERATE ACCURATE REFERENCE GENOMES FOR MICROBIAL IDENTIFICATION 53
8.5 METATRANSCRIPTOMICS 54
8.5.1 METATRANSCRIPTOMICS HELPS IN THE UNDERSTANDING OF THE ACTIVE FUNCTIONAL PROFILE OF A MICROBIAL COMMUNITY 54
9 METAGENOMIC SEQUENCING MARKET, BY APPLICATION 56
9.1 INTRODUCTION 57
9.2 DRUG DISCOVERY 57
9.2.1 DRUG DISCOVERY ACCOUNTS FOR THE LARGEST SHARE OF THE METAGENOMIC SEQUENCING MARKET 57
9.3 ECOLOGICAL & ENVIRONMENTAL APPLICATIONS 58
9.3.1 METAGENOMIC SEQUENCING CAN HELP IDENTIFY INVASIVE AND ENDANGERED SPECIES 58
9.4 CLINICAL DIAGNOSTICS 59
9.4.1 ADVANTAGES OF METAGENOMIC NGS HAVE ENABLED WIDE APPLICATIONS IN DIAGNOSTICS 59
9.5 SOIL MICROBIOME APPLICATIONS 60
9.5.1 NORTH AMERICA SHOWS HIGH DEMAND FOR METAGENOMIC SEQUENCING IN SOIL MICROBIOME APPLICATIONS 60
9.6 INDUSTRIAL APPLICATIONS 61
9.6.1 ENERGY 62
9.6.1.1 Declining fossil fuel reserves and growing energy needs will drive demand growth in this application segment 62
9.6.2 BIOREMEDIATION 63
9.6.2.1 Need to monitor pollutant impact and contamination will provide opportunities for metagenomic sequencing in bioremediation 63
9.6.3 OTHER INDUSTRIAL APPLICATIONS 64
9.7 VETERINARY APPLICATIONS 64
9.7.1 DEMAND FOR RAPID AND ACCURATE PATHOGEN DIAGNOSIS IS SUPPORTING DEMAND FOR SEQUENCING 64
9.8 OTHER APPLICATIONS 65
?
10 METAGENOMIC SEQUENCING MARKET, BY REGION 67
10.1 INTRODUCTION 68
10.2 NORTH AMERICA 68
10.2.1 US 72
10.2.1.1 Well-established infrastructure and funding sources required for overall NGS based small- and medium-sized research studies and projects make the US the largest market in North America 72
10.2.2 CANADA 73
10.2.2.1 Growing focus of NGS players on expanding their presence in Canada and increasing government initiatives to support genomics research and workshops to support growth in this market 73
10.3 EUROPE 74
10.3.1 GERMANY 77
10.3.1.1 Germany has witnessed a significant increase in investments in next-generation technologies, making it the largest market in Europe 77
10.3.2 UK 78
10.3.2.1 The UK is one of the leaders in biotechnology in the European region owing to the presence of a large number of NGS players in
the country 78
10.3.3 FRANCE 79
10.3.3.1 Government initiatives to support genomics research are primarily driving the growth of the metagenomic sequencing market in France 79
10.3.4 REST OF EUROPE 80
10.4 ASIA PACIFIC 81
10.4.1 CHINA 85
10.4.1.1 Several NGS players are focusing on strengthening their presence and offerings in China 85
10.4.2 JAPAN 86
10.4.2.1 Rising use of metagenomic sequencing for various application to drive market growth in Japan 86
10.4.3 INDIA 87
10.4.3.1 Decreasing cost of sequencing to drive market growth in India 87
10.4.4 REST OF ASIA PACIFIC 88
10.5 REST OF THE WORLD 89
10.5.1 LATIN AMERICA 92
10.5.2 MIDDLE EAST 93
10.5.3 AFRICA 94
11 COMPETITIVE LANDSCAPE 95
11.1 INTRODUCTION 95
11.2 MARKET RANKING ANALYSIS 95
11.3 COMPETITIVE SCENARIO 96
11.3.1 ACQUISITIONS 96
11.3.2 AGREEMENTS 97
?
11.4 COMPETITIVE LEADERSHIP MAPPING 98
11.4.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2018) 98
11.4.2 VISIONARY LEADERS 98
11.4.3 INNOVATORS 98
11.4.4 DYNAMIC PLAYERS 98
11.4.5 EMERGING COMPANIES 99
12 COMPANY PROFILES 100
(Business overview, Products and Services offered, Recent developments, MNM view)*
12.1 BGI GROUP 100
12.2 DNASTAR, INC. 103
12.3 EUROFINS SCIENTIFIC 104
12.4 GENEWIZ 107
12.5 ILLUMINA, INC. 110
12.6 INTEGRAGEN SA 115
12.7 MACROGEN, INC. 117
12.8 MICROSYNTH AG 119
12.9 NOVOGENE CO., LTD. 120
12.10 NUGEN TECHNOLOGIES, INC. (A WHOLLY OWNED SUBSIDIARY OF TECAN TRADING AG) 122
12.11 OXFORD NANOPORE TECHNOLOGIES, LTD. 125
12.12 PERKINELMER, INC. 128
12.13 QIAGEN N.V. 131
12.14 THERMO FISHER SCIENTIFIC, INC. 136
12.15 ZYMO RESEARCH CORPORATION 140
*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies
13 APPENDIX 142
13.1 DISCUSSION GUIDE 142
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 146
13.3 AVAILABLE CUSTOMIZATIONS 148
13.4 RELATED REPORTS 148
13.5 AUTHOR DETAILS 149